Glucose transporter 1 deficiency, AMP-activated protein kinase activation and immune dysregulation in autism spectrum disorder: Novel biomarker sources for clinical diagnosis
The neurophysiological basis of autism spectrum disorder (ASD) is still uncertain. Nevertheless, studies support the hypotheses that oxidative stress, neuroinflammation, immune dysregulation, and metabolic stress are contributors. In this study, the serum levels of 3-nitrotyrosine (3-NT), hypoxia-in...
Main Author: | Widad M. Al-Bishri |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Saudi Journal of Biological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319562X23002942 |
Similar Items
-
Hypothalamic AMP-Activated Protein Kinase as a Whole-Body Energy Sensor and Regulator
by: Se Hee Min, et al.
Published: (2024-02-01) -
Effects of Bofu-Tsusho-San on Diabetes and Hyperlipidemia Associated with AMP-Activated Protein Kinase and Glucose Transporter 4 in High-Fat-Fed Mice
by: Cheng-Hsiu Lin, et al.
Published: (2014-11-01) -
Identification of casein kinase 1, casein kinase 2, and cAMP-dependent protein kinase-like activities in Trypanosoma evansi
by: José Manuel Galán-Caridad, et al.
Published: (2004-12-01) -
Ginsenoside compound-Mc1 attenuates oxidative stress and apoptosis in cardiomyocytes through an AMP-activated protein kinase–dependent mechanism
by: So-hyeon Hong, et al.
Published: (2020-07-01) -
AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?
by: Fiona M. Russell, et al.
Published: (2020-12-01)